Surbhi Singhal, MD, of the University of California Davis, discussed disparities in biomarker testing among patients diagnosed with stage IV nonsquamous non–small cell lung cancer (NSCLC).
Surbhi Singhal, MD
Advertisement
Study author Surbhi Singhal, MD, is an assistant professor in the Division of Oncology at the University of California Davis and thoracic medical oncologist at the UC Davis Comprehensive Cancer Center.
Articles by Surbhi Singhal, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Cytokines Linked With Drug Resistance in Ovarian Cancer, but Underlying Mechanisms Remain Unclear
2
Mepolizumab Reduces Health Care Resource Utilization, Work Impairment in Severe Asthma
3
CHEST 2025 Highlights: Future of Respiratory Vaccines and the Impact of Federal Funding Cuts
4
Elinzanetant Shows Consistent Efficacy, Safety, and Sleep Benefits Across Studies
5
